The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment

Hwong, Alison R; Sah, Sunita; Lehmann, Lisa Soleymani

doi:10.1007/s11606-017-4122-y

Cited by 50 publications

(47 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, one factor that has been shown to influence patient opinion is their perception of physicians' conflicts of interest, especially sponsorships from for-profit entities. 3 An inverse relationship exists between how much funding a physician is perceived to have received from industry and how high a trust rating patients assign to him/her. 3 Public media scrutiny has influenced this decline in trust.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pitfalls and Safeguards in Industry-Funded Research

Breault

Knafl

2020

TOJ

View full text Add to dashboard Cite

Background: Physicians should follow ethical principles in their relationships with industry and be mindful that such relationships-if they are perceived as conflicts of interest-can undermine trust in the patient-physician relationship. Methods: By identifying potential pitfalls and safeguards that can help prevent problems, this article focuses on ensuring that physician-industry relationships do not result in ethical transgressions or cause damage to doctor-patient relationships. Results: Patient trust in physicians can be undermined by the perception that a physician-investigator is operating in the best interest of the research rather than the best interest of the patient. Payments from the pharmaceutical industry to physicianinvestigators are transparent because of the Sunshine Act, and patients can easily determine if their personal physicians have received money from industry. Research subsidies from industry should represent fair market value for the work performed. Postmarketing trials with the primary goal of increasing familiarity with a drug and prescribing rates should be avoided. Medical societies play an important role in establishing standards for professional conduct. Conclusion: Ethically sound actions in physician relationships with industry should be guided by professional standards, medical society guidelines, and local institutional policies.

show abstract

Section: Introductionmentioning

confidence: 99%

“…3 An inverse relationship exists between how much funding a physician is perceived to have received from industry and how high a trust rating patients assign to him/her. 3 Public media scrutiny has influenced this decline in trust. A 2012 article in The Washington Post told the story of the diabetes drug Avandia (rosiglitazone).…”

Section: Introductionmentioning

confidence: 99%

Pitfalls and Safeguards in Industry-Funded Research

Breault

Knafl

2020

TOJ

View full text Add to dashboard Cite

show abstract

“…Findings from survey and experimental studies on the relationship between patient trust and disclosure of industry ties have been mixed. Some studies 23 , 24 found that patients report higher levels of trust in physicians who disclose their industry relationships, while other studies 25 , 26 , 27 , 28 demonstrated lower levels of patient trust when physician financial conflicts of interest are disclosed.…”

Section: Introductionmentioning

confidence: 99%

US Nationwide Disclosure of Industry Payments and Public Trust in Physicians

2019

View full text Add to dashboard Cite

IMPORTANCE Transparency of industry payments to physicians could engender greater public trust in physicians but might also lead to greater mistrust of physicians and the medical profession, adversely affecting the patient-physician relationship. OBJECTIVE To examine the association between nationwide public disclosure of industry payments and Americans' trust in their physicians and trust in the medical profession. DESIGN, SETTING, AND PARTICIPANTS Survey study using difference-indifference analyses of a national longitudinal survey comparing changes in states where industry payments were newly disclosed by Open Payments with changes in states where payments information was already available because of state sunshine laws. The US population-based surveys were conducted in September 2014-shortly before the initial public disclosure of industry payments-and again in September 2016. Final analyses were conducted September through December 2018. Participants were adults 18 years and older (n = 1388). EXPOSURES National public disclosure through Open Payments of payments made by pharmaceutical and medical device firms to physicians. MAIN OUTCOMES AND MEASURES Wake Forest measure of trust in one's own physician and Wake Forest measure of trust in the medical profession. RESULTS Of the 3542 original survey respondents, 2180 (61.5%) completed the second survey 2 years later, and 1388 named the same most frequently seen physician in both surveys. The mean age of respondents at the time of the first survey was 53 years, and 749 (54.0%) were women. Race/ ethnicity was white in 76.6% (1063 of 1388) and non-Hispanic black in 8.0% (111 of 1388). Public disclosure of payments was associated with lower trust in one's own physician regardless of whether respondents knew their physicians had received payments (decrease in Wake Forest measure of trust in one's own physician of 0.56 point; 95% CI, −0.79 to −0.32 point; P < .001). Open Payments was also associated with lower trust in the medical profession (decrease in Wake Forest measure of trust in the medical profession of 0.35 point; 95% CI, −0.58 to −0.12 point; P = .004). CONCLUSIONS AND RELEVANCE Nationwide public disclosure of industry payments may be associated with decreased trust in physicians and in the medical profession. More judicious presentation of payments information may counteract unintended negative trust and spillover consequences of public disclosure.

show abstract

“…The authors chose ProPublica's website and divided participants into four study arms to view physicians who received no payment, low payments, or high payments from industry, or physicians who provided no disclosure. 3 Only 278 English-speaking adults participated and were given the names of senior male physicians practicing internal medicine in Massachusetts. Only 19 participants found their own doctors listed on the disclosure website.…”

mentioning

confidence: 99%

“…Additionally, there were no differences between disclosure and no disclosure arms for any trust dimensions for the medical profession or industry. 3 The Physician Payments Sunshine Act mandates public disclosure of all industry payments to physicians, and has resulted in greater scrutiny of industry's relationship with physicians; however, payments to nurse practitioners and physician assistants are not covered. 4 Despite several limitations, including small sample size and limited availability of data within the ProPublica website, this study does add limited value to the growing body of literature on payment disclosures by physicians in various specialties.…”

mentioning

confidence: 99%

Capsule Commentary on Hwong et al., The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment

Mohammad

2017

J GEN INTERN MED

View full text Add to dashboard Cite

The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment

Cited by 50 publications

References 38 publications

Pitfalls and Safeguards in Industry-Funded Research

Pitfalls and Safeguards in Industry-Funded Research

US Nationwide Disclosure of Industry Payments and Public Trust in Physicians

Capsule Commentary on Hwong et al., The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment

Contact Info

Product

Resources

About